AI Article Synopsis

  • This study examines the impact of human papillomavirus (HPV) status on patients undergoing salvage radiation therapy for recurring and new head and neck cancers, specifically in areas already treated with radiation.
  • It involved analyzing medical records of 54 patients to determine survival rates, with findings indicating that patients with HPV-positive tumors had a trend toward better overall and progression-free survival compared to those with HPV-negative or unknown status.
  • The results suggest that understanding a patient's HPV status could help in assessing their prognosis and tailoring treatment plans.

Article Abstract

Purpose: To evaluate the prognostic significance of human papillomavirus (HPV) status among patients treated by salvage radiation therapy for local-regional recurrences and second primary cancers of the head and neck arising in a previously irradiated field.

Methods And Materials: The medical records of 54 consecutive patients who underwent re-irradiation for squamous cell carcinoma of the head and neck occurring in a previously irradiated field were reviewed. Only patients with biopsy-proven evidence of recurrent disease that had previously been treated with doses of radiation therapy of at least 60 Gy were included. Determination of HPV status at the time of recurrence was performed by p16 immunohistochemistry. The median age at re-irradiation was 58.5 years (range, 27.9 to 81.5 years). Thirty patients (55.5%) were lifelong never-smokers. The Kaplan Meier method was used to calculate overall survival, progression-free survival, and local-regional control, and distant metastasis-free survival with comparisons between groups performed using the log-rank test.

Results: HPV status among tumors that were re-irradiated was as follows: 16 positive (29.7%); 7 negative (12.9%); 31 unknown (57.4%). The median overall survival in the entire cohort was 11.7 months (range, 8 to 27 months), with the 1-year and 2-year estimates of overall survival being 47.2% and 38.4%, respectively. A statistical trend was identified favoring patients with HPV-positive cancers with respect to the endpoints of overall survival (p = 0.06) and progression-free survival (p = 0.08) after re-irradiation when compared to the HPV-negative/unknown population. There was no significant difference in distant control between the two cohorts (p = 0.40).

Conclusions: The favorable prognostic significance of HPV seemingly extends to patients treated by re-irradiation suggesting that this biomarker may be useful in risk stratification in this setting.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjoto.2018.01.011DOI Listing

Publication Analysis

Top Keywords

hpv status
16
prognostic significance
12
head neck
12
significance hpv
8
second primary
8
primary cancers
8
cancers head
8
patients treated
8
radiation therapy
8
progression-free survival
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!